We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-3.31%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$2.38B
AUM Growth
+$407M
Cap. Flow
+$540M
Cap. Flow %
22.68%
Top 10 Hldgs %
32.09%
Holding
169
New
35
Increased
72
Reduced
38
Closed
24

Top Sells

Rank Stock Value
1
COUR icon
Coursera
COUR
+$25.2M
2
APP icon
Applovin
APP
+$22.4M
3
CTSH icon
Cognizant
CTSH
+$20.7M
4
CPAY icon
Corpay
CPAY
+$19.5M
5
AKAM icon
Akamai
AKAM
+$18.1M

Sector Composition

Rank Sector Weight
1 Technology 23.13%
2 Communication Services 13.73%
3 Healthcare 12.21%
4 Consumer Discretionary 11.73%
5 Energy 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRN
26
DELISTED
Veren
VRN
$25M 1.05%
3,010,280
+680,148
+29% +$5.42M
CNC icon
27
Centene
CNC
$32.5B
$24.3M 1.02%
352,421
-255,079
-42% -$17M
PINC
28
DELISTED
Premier
PINC
$23.6M 0.99%
1,097,489
+267,747
+32% +$6.68M
APP icon
29
Applovin
APP
$116B
$23.3M 0.98%
583,413
-631,784
-52% -$22.4M
TDS icon
30
Telephone and Data Systems
TDS
$3.75B
$22.4M 0.94%
1,224,374
+1,017,183
+491% +$14.7M
SMAR
31
DELISTED
Smartsheet Inc.
SMAR
$22M 0.93%
544,877
+369,161
+210% +$15.1M
BPOP icon
32
Popular Inc
BPOP
$11.1B
$21.8M 0.91%
345,588
-46,534
-12% -$3.08M
EGO icon
33
Eldorado Gold
EGO
$9.89B
$20.4M 0.86%
2,289,734
+52,386
+2% +$510K
BAX icon
34
Baxter International
BAX
$14.2B
$20.2M 0.85%
534,536
+13,589
+3% +$579K
NOMD icon
35
Nomad Foods
NOMD
$1.68B
$20.2M 0.85%
1,324,462
+55,514
+4% +$960K
UDMY
36
DELISTED
Udemy
UDMY
$20.1M 0.85%
2,118,403
+81,361
+4% +$851K
SSTK icon
37
Shutterstock
SSTK
$219M
$19.9M 0.83%
521,892
+316,114
+154% +$14.2M
NVEI
38
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$19.8M 0.83%
1,181,152
+624,207
+112% +$14.5M
LAZ icon
39
Lazard
LAZ
$4.31B
$19.1M 0.8%
616,981
-51,698
-8% -$1.73M
LEVI icon
40
Levi Strauss
LEVI
$9.39B
$19.1M 0.8%
1,402,829
+208,128
+17% +$2.91M
CVS icon
41
CVS Health
CVS
$122B
$18.5M 0.78%
265,576
+52,356
+25% +$3.71M
VET icon
42
Vermilion Energy
VET
$1.66B
$17.6M 0.74%
1,205,911
+949,761
+371% +$13.4M
BTG icon
43
B2Gold
BTG
$6.64B
$16.8M 0.71%
5,859,005
-320,716
-5% -$1.04M
UA icon
44
Under Armour Class C
UA
$2.53B
$16.8M 0.7%
2,629,502
+1,194,425
+83% +$8.23M
FL
45
DELISTED
Foot Locker
FL
$16.6M 0.7%
+954,241
New +$21.3M
CXW icon
46
CoreCivic
CXW
$3.19B
$16.5M 0.69%
1,462,646
+847,717
+138% +$8.52M
TRIP icon
47
TripAdvisor
TRIP
$1.26B
$16.1M 0.67%
968,810
+309,100
+47% +$5.04M
LRN icon
48
Stride
LRN
$3.43B
$16M 0.67%
355,190
+171,591
+93% +$6.98M
SHEL icon
49
Shell
SHEL
$245B
$15.8M 0.66%
+244,762
New +$15.2M
SWN
50
DELISTED
Southwestern Energy Company
SWN
$15.7M 0.66%
2,436,042
+61,664
+3% +$393K

Similar funds

Invenomic Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Invenomic Capital Management held 169 positions worth $2.38B, up 21% from $1.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Invenomic Capital Management deployed $540M of net new capital in Q3 2023, opening 35 new positions and adding to 72 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 550,000 shares worth $235M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 27% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Applovin, an estimated $22.4M trimmed.

  • Invenomic Capital Management's largest Q3 2023 buy was State Street SPDR S&P 500 ETF Trust: 550,000 shares worth $235M.
  • Invenomic Capital Management added most to Citigroup in Q3 2023, an estimated $37.9M increase.
  • Invenomic Capital Management's biggest Q3 2023 reduction was Applovin, cutting an estimated $22.4M.
  • Invenomic Capital Management fully exited Coursera in Q3 2023, selling an estimated $25.2M.
  • Invenomic Capital Management's ten largest holdings make up 32% of its $2.38B portfolio in Q3 2023.
  • Invenomic Capital Management opened 35 new positions and closed 24 in Q3 2023.
  • Invenomic Capital Management's portfolio value rose 21% quarter-over-quarter to $2.38B.

Based on Invenomic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.